In a Phase III trial of 886 patients, Keytruda, a PD-1 inhibitor, plus Padcev, an antibody-drug conjugate, reduced the risk of death by 53% over platinum-based chemotherapy
GLP-1 receptor agonists slow gastric motility, which can shift the time-to-peak (Tmax) of orally administered drugs
If no nausea occurs, the dose can be increased by 50-100mcg weekly until reaching 250-500mcg or until clinical endpoints are achieved
Sustainable treatment will likely require combination approaches, longer-term strategies, and therapies that reshape how the brain interprets energy balance, not just how much people eat, he said
Bariatric surgery and longitudinal cancer risk: a review
Probiotic-rich foods: Yogurt, kefir, sauerkraut, kimchi, and other fermented foods support the microbiome populations that protect against UTIs